Back

Post-mortem evidence for a reciprocal relationship between genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies.

Koss, D. J.; Todd, O. J. G.; Menon, H.; Anderson, Z. A.; Yang, T.; Attems, J.; LeBeau, F. E.; Erskine, D.; Outeiro, T. F.

2024-04-28 neuroscience
10.1101/2024.04.24.590825 bioRxiv
Show abstract

DNA damage and DNA damage repair (DDR) dysfunction are insults with broad implications on cellular physiology, including in proteostasis, and have been recently implicated in many neurodegenerative diseases. Alpha-synuclein (aSyn), a pre-synaptic and nuclear protein associated with neurodegenerative disorders known as synucleinopathies, has been implicated in DNA double strand break (DSB) repair function. Consistently, DSB induction has been demonstrated in cell and animal models of synucleinopathy. Nevertheless, the types of DNA damage and the contribution of DNA damage towards Lewy body (LB) formation in synucleinopathies are unknown. Here, we demonstrate the increase of DSB in neuronal and non-neuronal cellular populations of post-mortem temporal cortex tissue from dementia with Lewy body (DLB) patients and demonstrate increases in DSBs early at a presymptomatic age of aSyn transgenic mice. Strikingly, in postmortem DLB tissue, DNA damage-derived ectopic cytoplasmic genomic material (eCGM) was evident within the majority of LBs examined. The observed cellular pathology was consistent with nucleoproteasomal upregulation of associated DNA damage repair proteins, particularly in base excision repair and DSB repair pathways. Collectively our study demonstrates the early occurrence of DNA damage and associated nucleoproteasomal changes in response to nuclear aSyn pathology. Furthermore, the data suggests a potential involvement for DNA damage derived eCGM for the facilitation of cytoplasmic aSyn aggregates. Ultimately, uncovering pathological mechanisms underlying DNA damage in DLB sheds light into novel disease mechanisms and opens novel possibilities for diagnosing and treating synucleinopathies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.1%
18.5%
2
Acta Neuropathologica Communications
81 papers in training set
Top 0.1%
14.3%
3
Brain
154 papers in training set
Top 0.4%
12.4%
4
Acta Neuropathologica
51 papers in training set
Top 0.1%
10.0%
50% of probability mass above
5
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
3.9%
6
Alzheimer's & Dementia
143 papers in training set
Top 1%
3.6%
7
Nature Communications
4913 papers in training set
Top 45%
2.4%
8
EMBO Molecular Medicine
85 papers in training set
Top 1%
2.3%
9
Brain Communications
147 papers in training set
Top 2%
1.7%
10
Scientific Reports
3102 papers in training set
Top 58%
1.7%
11
Cell Reports
1338 papers in training set
Top 24%
1.7%
12
Cell Death & Disease
126 papers in training set
Top 1%
1.7%
13
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 36%
1.3%
14
PLOS Genetics
756 papers in training set
Top 11%
1.2%
15
Advanced Science
249 papers in training set
Top 14%
1.2%
16
Science Advances
1098 papers in training set
Top 24%
1.1%
17
eneuro
389 papers in training set
Top 8%
0.9%
18
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
19
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.6%
0.8%
20
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%
21
International Journal of Molecular Sciences
453 papers in training set
Top 16%
0.7%
22
JCI Insight
241 papers in training set
Top 8%
0.7%
23
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.7%
24
The EMBO Journal
267 papers in training set
Top 6%
0.7%
25
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.6%
26
Aging Cell
144 papers in training set
Top 4%
0.6%
27
Journal of Alzheimer's Disease
43 papers in training set
Top 1%
0.6%